Matching Items (2,112)
Filtering by

Clear all filters

Description
Axon Enterprise, Inc. is a publicly traded company founded in Scottsdale, Arizona in 1993. The company went public on June 7th, 2001. The inspiration for this topic is our interest in equity research. We believe that understanding how to fundamentally research a company is not only beneficial for our careers,

Axon Enterprise, Inc. is a publicly traded company founded in Scottsdale, Arizona in 1993. The company went public on June 7th, 2001. The inspiration for this topic is our interest in equity research. We believe that understanding how to fundamentally research a company is not only beneficial for our careers, but for our own personal financial learning. One thing that stood out about Axon was its dominant control of the stun gun market. Axon captures around 90%.. Because of this, we wanted to dive deeper. Surely, this has to be a good investment. What company owns almost all of the market share but isn’t a good investment? In our heads, none. But that wasn’t enough. We wanted to dive deeper and examine the fundamental business mechanisms of the firm to determine for ourselves why this is, and why we believe the company really does have tremendous growth potential. By connecting with Axon executives, developing an investment thesis, and understanding the fundamental business drivers behind Axon, we will develop a thorough understanding of Axon’s financial standing. Our goals; fundamental analysis of Axon, determine a one year price target, convince readers that Axon is a rewarding and appealing investment opportunity.
ContributorsGreife, Torsten Markus (Co-author) / Bailey, Eric (Co-author) / Budolfson, Arthur (Thesis director) / Licon, Lawrence (Committee member) / Department of Supply Chain Management (Contributor) / Dean, W.P. Carey School of Business (Contributor) / Barrett, The Honors College (Contributor)
Created2019-05
173937-Thumbnail Image.png
Description

Leonard Hayflick studied the processes by which cells age during the twentieth and twenty-first centuries in the United States. In 1961 at the Wistar Institute in the US, Hayflick researched a phenomenon later called the Hayflick Limit, or the claim that normal human cells can only divide forty to sixty

Leonard Hayflick studied the processes by which cells age during the twentieth and twenty-first centuries in the United States. In 1961 at the Wistar Institute in the US, Hayflick researched a phenomenon later called the Hayflick Limit, or the claim that normal human cells can only divide forty to sixty times before they cannot divide any further. Researchers later found that the cause of the Hayflick Limit is the shortening of telomeres, or portions of DNA at the ends of chromosomes that slowly degrade as cells replicate. Hayflick used his research on normal embryonic cells to develop a vaccine for polio, and from HayflickÕs published directions, scientists developed vaccines for rubella, rabies, adenovirus, measles, chickenpox and shingles.

Created2014-07-20
173939-Thumbnail Image.png
Description

Although best known for his work with the fruit fly, for which he earned a Nobel Prize and the title "The Father of Genetics," Thomas Hunt Morgan's contributions to biology reach far beyond genetics. His research explored questions in embryology, regeneration, evolution, and heredity, using a variety of approaches.

Created2007-09-25
173947-Thumbnail Image.jpg
Created1935